Banque Transatlantique’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Banque Transatlantique’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$751K	Buy	+7,587	New	+$684K	0.02%	188

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

MCM

Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

AWM

Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return

FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Banque Transatlantique's IHE Position: Q2 2026 in Review

Banque Transatlantique opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 7,587 shares worth $751K. The stake represents 0.02% of the portfolio and ranks #188 among its holdings.

120 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Banque Transatlantique held 7,587 shares of iShares US Pharmaceuticals ETF worth $751K as of Q2 2026.
iShares US Pharmaceuticals ETF was a new Banque Transatlantique position in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.02% of Banque Transatlantique's portfolio in Q2 2026, its #188 holding.
120 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.